Masimo Corporation (MASI): Price and Financial Metrics
MASI Price/Volume Stats
Current price | $95.41 | 52-week high | $198.00 |
Prev. close | $97.03 | 52-week low | $95.31 |
Day low | $95.31 | Volume | 467,800 |
Day high | $97.65 | Avg. volume | 598,489 |
50-day MA | $112.91 | Dividend yield | N/A |
200-day MA | $153.70 | Market Cap | 5.04B |
MASI Stock Price Chart Interactive Chart >
MASI POWR Grades
- Value is the dimension where MASI ranks best; there it ranks ahead of 73.32% of US stocks.
- The strongest trend for MASI is in Sentiment, which has been heading down over the past 179 days.
- MASI's current lowest rank is in the Momentum metric (where it is better than 7.42% of US stocks).
MASI Stock Summary
- MASI's current price/earnings ratio is 45.52, which is higher than 86.53% of US stocks with positive earnings.
- The price/operating cash flow metric for MASIMO CORP is higher than 98.68% of stocks in our set with a positive cash flow.
- As for revenue growth, note that MASI's revenue has grown 45.33% over the past 12 months; that beats the revenue growth of 87.74% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to MASIMO CORP are MOG.A, ULBI, GNRC, NSSC, and FEIM.
- MASI's SEC filings can be seen here. And to visit MASIMO CORP's official web site, go to www.masimo.com.
MASI Valuation Summary
- In comparison to the median Healthcare stock, MASI's price/earnings ratio is 66.97% higher, now standing at 45.5.
- MASI's EV/EBIT ratio has moved up 23.1 over the prior 196 months.
Below are key valuation metrics over time for MASI.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
MASI | 2023-09-18 | 2.4 | 4.0 | 45.5 | 37.9 |
MASI | 2023-09-15 | 2.4 | 4.1 | 46.1 | 38.3 |
MASI | 2023-09-14 | 2.5 | 4.1 | 46.7 | 38.7 |
MASI | 2023-09-13 | 2.4 | 4.1 | 46.2 | 38.4 |
MASI | 2023-09-12 | 2.4 | 4.0 | 44.9 | 37.4 |
MASI | 2023-09-11 | 2.5 | 4.2 | 47.9 | 39.6 |
MASI Growth Metrics
- Its 2 year revenue growth rate is now at 27.52%.
- Its 4 year revenue growth rate is now at 37.48%.
- Its 4 year net cashflow from operations growth rate is now at -46.42%.

The table below shows MASI's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 2,035.8 | 29.4 | 143.5 |
2022-09-30 | 1,746.419 | 133.603 | 170.853 |
2022-06-30 | 1,504.533 | 205.096 | 190.724 |
2022-03-31 | 1,244.351 | 228.652 | 222.859 |
2021-12-31 | 1,239.153 | 264.754 | 229.647 |
2021-09-30 | 1,206.629 | 231.569 | 232.058 |
MASI's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- MASI has a Quality Grade of B, ranking ahead of 88.45% of graded US stocks.
- MASI's asset turnover comes in at 0.714 -- ranking 51st of 186 Medical Equipment stocks.
- BLFS, NVNO, and ZYXI are the stocks whose asset turnover ratios are most correlated with MASI.
The table below shows MASI's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-10-02 | 0.714 | 0.647 | 0.384 |
2021-07-03 | 0.702 | 0.642 | 0.380 |
2021-04-03 | 0.705 | 0.643 | 0.387 |
2021-01-02 | 0.700 | 0.650 | 0.408 |
2020-09-26 | 0.705 | 0.660 | 0.413 |
2020-06-27 | 0.720 | 0.669 | 0.414 |
MASI Price Target
For more insight on analysts targets of MASI, see our MASI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $298.80 | Average Broker Recommendation | 1.56 (Moderate Buy) |
Masimo Corporation (MASI) Company Bio
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies worldwide. The Company's core business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. The company was founded in 1989 and is based in Irvine, California.
Latest MASI News From Around the Web
Below are the latest news stories about MASIMO CORP that investors may wish to consider to help them evaluate MASI as an investment opportunity.
Masimo to Present in Wells Fargo Healthcare ConferenceIRVINE, Calif., September 07, 2023--Masimo (NASDAQ: MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Friday, September 8, 2023 at 9:30 a.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. |
Masimo's (MASI) Inks Agreement to Improve Patient OutcomesMasimo's (MASI) latest deal with FMOLHS is expected to enhance patient safety and improve patient outcomes. |
Franciscan Missionaries of Our Lady Health System and Masimo Sign Multi-year, System-wide Monitoring AgreementIRVINE, Calif., August 31, 2023--The 10-hospital Franciscan Missionaries of Our Lady Health System is adopting multiple Masimo technologies. |
Masimo's (MASI) Stork Baby Monitor Now Available Across U.S.The latest U.S. availability of Masimo's (MASI) Stork smart home baby monitoring system is likely to provide a continuous and accurate view of babies' health data. |
Masimo Announces Full Market Release of Stork™ Smart Home Baby MonitorIRVINE, Calif., August 23, 2023--The Masimo Stork™ smart home baby monitoring system is now available in the U.S. for purchase online and on shelves at major and specialty retailers. |
MASI Price Returns
1-mo | -13.85% |
3-mo | -41.38% |
6-mo | -44.73% |
1-year | -32.94% |
3-year | -56.22% |
5-year | -23.04% |
YTD | -35.51% |
2022 | -49.47% |
2021 | 9.09% |
2020 | 69.80% |
2019 | 47.21% |
2018 | 26.62% |
Continue Researching MASI
Want to see what other sources are saying about Masimo Corp's financials and stock price? Try the links below:Masimo Corp (MASI) Stock Price | Nasdaq
Masimo Corp (MASI) Stock Quote, History and News - Yahoo Finance
Masimo Corp (MASI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...